EPCAM and neoplasm: It is obvious that immuno‐biochemical techniques targeting antigens like EpCAM are not infallible for all tumor entities or heterogeneous CTC populations, especially CTCs undergoing epithelial‐mesenchymal transition (EMT) which is closely linked to invasive metastasis.